Releases & Announcements | National Center for Advancing Translational Sciences

Skip to main content

U.S. Department of Health & Human Services

National Institutes of Health

COVID-19

Get the latest public health information from CDC.
Get the latest research information from NIH. | Español

In the Spotlight

NIH laboratory team performs serology to detect antibodies to the SARS-CoV-2, the virus that causes COVID-19. NIBIB photo.

NIH Study Suggests COVID-19 Prevalence Far Exceeded Early Pandemic Cases

NIBIB ∙ 06/22/2021 ∙ CTSA Program

Drug repurposing is not a new concept brought about by COVID-19. In recent years, drug repurposing has been gaining traction in the medical community because of its time and cost savings and potential patient care benefits. In fact, FDA and NCATS formally launched the CURE ID application in December 2019. CURE ID allows health care providers to report new uses of existing drugs for 325 difficult-to-treat, infectious diseases through a standardized and simple case report form from a website or mobile device.

July 2021

More than Two Hours of Daily Screen Time Linked to Cognitive, Behavioral Problems in Children Born Extremely Preterm
NCATS, NICHD ∙ 07/15/2021 ∙ CTSA Program

June 2021

Study Links Sleep Apnea in Children to Increased Risk of High Blood Pressure in Teen Years
NCATS, NHLBI ∙ 06/23/2021 ∙ CTSA Program
NIH Study Suggests COVID-19 Prevalence Far Exceeded Early Pandemic Cases
NIBIB ∙ 06/22/2021 ∙ CTSA Program

May 2021

Scientists Identify Small-Molecule Cocktail to Improve Stem Cell Use in Research and Disease Treatments
NCATS ∙ 05/03/2021 ∙ Stem Cell Translation Laboratory

April 2021

Dr. Andrew Singleton to Direct New NIH Research Laboratory for Alzheimer’s and Related Dementias Research
NCATS, NIA ∙ 04/26/2021 ∙ Division of Preclinical Innovation
Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19 Symptoms
NCATS ∙ 04/19/2021 ∙ CTSA Program
Drug Testing Approach Uncovers Effective Combination for Treating Small Cell Lung Cancer
NCATS ∙ 04/12/2021 ∙ Division of Preclinical Innovation
NIH-Funded Research Team Develops Language Test for People with Down Syndrome
NCATS, NICHD ∙ 04/08/2021 ∙ CTSA Program

March 2021

Dr. Christopher P. Austin to Step Down as NCATS Director
NCATS ∙ 03/18/2021 ∙ Director's Statement
NIH Statement on the Departure of Dr. Christopher Austin
The NIH Director ∙ 03/18/2021 ∙ NCATS, NIH
Assessing a Compound’s Activity, Not Just Its Structure, Could Deepen the Pool of Promising Drug Therapies
NCATS ∙ 03/03/2021 ∙ Division of Preclinical Innovation
NCATS Director Statement in Support of Ending Structural Racism and Health Disparities
NCATS ∙ 03/01/2021 ∙ Director's Statement

January 2021

DNA-Editing Method Shows Promise to Treat Mouse Model of Progeria
NCATS, NHGRI ∙ 01/06/2021 ∙ Somatic Cell Genome Editing

December 2020

Higher Red Cell Transfusion Threshold Offers No Advantage for Treating Preterm Infants
NCATS, NICHD, NHLBI ∙ 12/30/2020 ∙ NIH
NIH to Support Radical Approaches to Nationwide COVID-19 Testing and Surveillance
NCATS, NIH ∙ 12/21/2020 ∙ NCATS

November 2020

PaVe-GT: Collaborative NIH Effort Aimed at Creating a Gene Therapy Playbook, Making Rare Disease Treatments More Accessible
NCATS ∙ 11/30/2020 ∙ Rare Diseases
Commonly Used Antibiotic Shows Promise for Combating Zika Infections
NCATS, NINDS ∙ 11/24/2020 ∙ Division of Preclinical Innovation
Hydroxychloroquine Does Not Benefit Adults Hospitalized with COVID-19
NCATS, NHLBI ∙ 11/09/2020 ∙ CTSA Program

October 2020

NCATS Team’s Rapid Test Finds Promising Therapies for Myositis
NCATS ∙ 10/22/2020 ∙ Rare Diseases
NIH Begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19
NCATS, NIH ∙ 10/16/2020 ∙ CTSA Program
NCATS Translational Science Training Program Sets Young Scientists on Paths to Career Success
NCATS ∙ 10/13/2020 ∙ Division of Preclinical Innovation

September 2020

NIH Awards $35.5 Million to Use Tiny, Bioengineered Organ Models to Improve Clinical Trials’ Development and Design
NCATS ∙ 09/29/2020 ∙ Tissue Chip
NIH Expands Clinical Trials to Test Convalescent Plasma Against COVID-19
NCATS, NIH ∙ 09/22/2020 ∙ CTSA Program
NCATS, NRL Create Nanoparticle SARS-CoV-2 Model to Speed Drug Discovery for COVID-19
NCATS ∙ 09/18/2020 ∙ TRND
Announcement: Access to the COVID-19 Data Analytics Platform Now Open
NCATS ∙ 09/02/2020 ∙
Study Ties COVID-19-Related Syndrome in Kids to Altered Immune System
NIH ∙ 09/01/2020 ∙ GARD

August 2020

Rare Diseases Are Not Rare: Gallery of Creative Work Raises Awareness of Rare Diseases
NCATS, NIH ∙ 08/25/2020 ∙ Rare Diseases
NIH-Supported Scientists Demonstrate How Genetic Variations Cause Eczema
NCATS, NIAID ∙ 08/14/2020 ∙ CTSA Program